Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Kelly

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial<sup>☆</sup>F Montemurro, S Delaloge, C H Barrios, et al.
Experimental Neurology|May 8, 2016
FoxP1 marks medium spiny neurons from precursors to maturity and is required for their differentiationS V Precious, C M Kelly, A E Reddington, et al.
Cell Death and Differentiation|January 8, 2011
Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cellsO Cordero-Llana, S A Scott, S L Maslen, et al.
Cell Transplantation|March 15, 2011
Medical terminations of pregnancy: a viable source of tissue for cell replacement therapy for neurodegenerative disordersC M Kelly, S V Precious, E M Torres, et al.
ESMO Open|June 5, 2024
Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-BF Marmé, M Martin, M Untch, et al.
Breast Cancer Research and Treatment|April 9, 2021
Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in IrelandL M McSorley, M Tharmabala, F Al Rahbi, et al.
Irish Journal of Medical Science|April 11, 2025
CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in IrelandW J Mullally, A Hassan, N Keegan, et al.
ESMO Open|July 27, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcomaE Rosenbaum, K Seier, M Bradic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2025
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy-PENELOPE-BS Loibl, M Martin, H Bonnefoi, et al.
Breast Cancer Research and Treatment|October 4, 2024
Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancerI M Browne, R A McLaughlin, C S Weadick, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial<sup>☆</sup>F Montemurro, S Delaloge, C H Barrios, et al.
Experimental Neurology|May 8, 2016
FoxP1 marks medium spiny neurons from precursors to maturity and is required for their differentiationS V Precious, C M Kelly, A E Reddington, et al.
Cell Death and Differentiation|January 8, 2011
Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cellsO Cordero-Llana, S A Scott, S L Maslen, et al.
Cell Transplantation|March 15, 2011
Medical terminations of pregnancy: a viable source of tissue for cell replacement therapy for neurodegenerative disordersC M Kelly, S V Precious, E M Torres, et al.
ESMO Open|June 5, 2024
Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-BF Marmé, M Martin, M Untch, et al.
Breast Cancer Research and Treatment|April 9, 2021
Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in IrelandL M McSorley, M Tharmabala, F Al Rahbi, et al.
Irish Journal of Medical Science|April 11, 2025
CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in IrelandW J Mullally, A Hassan, N Keegan, et al.
ESMO Open|July 27, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcomaE Rosenbaum, K Seier, M Bradic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2025
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy-PENELOPE-BS Loibl, M Martin, H Bonnefoi, et al.
Breast Cancer Research and Treatment|October 4, 2024
Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancerI M Browne, R A McLaughlin, C S Weadick, et al.
Pageof 9